InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Tak Paul Peter, Chief Executive Officer. Officer active across 1 companies, notably Candel Therapeutics, Inc.. Cumulatively, 2 reports have been published. Total volume traded: €336k. The latest transaction was filed on 29 July 2021 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations2 total
€168,16625,000 shares@ €6.7266100.0% of flow
Common Stock
SEC:0000899243-21-031097·
Ideal exit: 25 Apr 2022 (T+270)
€168,16625,000 shares@ €6.72660.054% mcap50.0% of flow
Common Stock
SEC:0000899243-21-031097:0·
Ideal exit: 25 Apr 2022 (T+270)
2 of 2 declarations
About Tak Paul Peter
Paul Peter Tak is the Chief Executive Officer at Candel Therapeutics, Inc. He is responsible for the overall direction of the company, overseeing operations and growth strategies. His role is essential for the success and performance of the business.
